Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib
Ruben A. Mesa, Srđan Verstovšek, Uwe Platzbecker, Vikas Gupta, David Lavie, Pilar Giraldo, Christian Récher, Jean‐Jacques Kiladjian, Stephen T. Oh, Aaron T. Gerds, Timothy Devos, Francesco Passamonti, Alessandro M. Vannucchi, Miklós Egyed, Ewa Lech‐Marańda, Andrzej Pluta, Lars Nilsson, Kazuya Shimoda, Donal P. McLornan, Jun Kawashima, Barbara Klencke, Mei Huang, Bryan Strouse, Claire Harrison
Abstract
Not available.
Topics & Concepts
RuxolitinibMyelofibrosisMedicineInternal medicineOncologyBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentKruppel-like factors researchChronic Myeloid Leukemia Treatments